A. Silbergeld

发表

Modulation of IGF‐I receptors by exogenous hGH treatment in constitutionally short children

Z. Laron, R. Eshet, B. Klinger, 1993, Clinical endocrinology.

SERUM GROWTH HORMONE BINDING PROTEIN ACTIVITY IN HEALTHY NEONATES, CHILDREN AND YOUNG ADULTS: CORRELATION WITH AGE, HEIGHT AND WEIGHT

Z. Laron, R. Tepper, L. Lazar, 1989, Clinical endocrinology.

Opposing Effects of Growth Hormone and Insulin-like Growth Factor I on Serum Lipoprotein(a)

Z. Laron, Xingmin Wang, B. Klinger, 1997 .

The interrelationship between and the regulation of hepatic growth hormone receptors and circulating GH binding protein in the pig.

P. Gluckman, B. Breier, H. Blair, 1992, Acta endocrinologica.

Increased number of IGF‐I receptors on erythrocytes of women with polycystic ovarian syndrome

Z. Laron, Y. Diamant, R. Eshet, 1997, Clinical endocrinology.

Comparative effects of GH, IGF‐I and insulin on serum sex hormone binding globulin

Z. Laron, A. Silbergeld, M. Gafny, 1994, Clinical endocrinology.

Laron syndrome due to a post-receptor defect: response to IGF-I treatment.

A. Karasik, Z. Laron, R. Eshet, 1993, Israel journal of medical sciences.

Patients with Laron Syndrome Have Osteopenia/Osteoporosis

Z. Laron, B. Klinger, A. Silbergeld, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.

Z. Laron, H. Schwartz, B. Klinger, 1992, Hormone research.

Insulin-like growth factor-I decreases serum lipoprotein (a) during long-term treatment of patients with Laron syndrome.

D. Wilcken, Z. Laron, X. L. Wang, 1996, Metabolism: clinical and experimental.

Growth Hormone Treatment Increases Circulating Lipoprotein(a) in Children with Chronic Renal Failure

D. Wilcken, Z. Laron, X.-L. Wang, 1996, Journal of pediatric endocrinology & metabolism : JPEM.

Differential effect of insulin-like growth factor-I and growth hormone on hypothalamic regulation of growth hormone secretion in the rat

Abraham Weizman, Z. Laron, Y. Koch, 1996, Journal of endocrinological investigation.

Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone

Z. Laron, I. Gil-ad, A. Pertzelan, 1992, Journal of endocrinological investigation.

A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.

M. Phillip, D. Landau, Y. Segev, 2001, Kidney international.

Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.

Z. Laron, B. Klinger, A. Silbergeld, 1989, Acta endocrinologica.

Serum Insulin-like Growth Factor-I (IGF-I) Levels During Long-term IGF-I Treatment of Children and Adults with Primary GH Resistance (Laron Syndrome)

Z. Laron, B. Klinger, A. Silbergeld, 1999, Journal of pediatric endocrinology & metabolism : JPEM.

Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels.

H. Werner, C. Roberts, D. Leroith, 1993, Journal of molecular endocrinology.

Serum Leptin in Obese Patients with Laron Syndrome Before and During IGF-I Treatment

Z. Laron, P. Lilos, A. Silbergeld, 1998, Journal of pediatric endocrinology & metabolism : JPEM.

Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity.

A. Karasik, H. Kanety, Z. Laron, 1993, Acta endocrinologica.

Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS)

Z. Laron, R. Eshet, B. Klinger, 1993, Regulatory Peptides.

Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein.

R. Baxter, A. Karasik, H. Kanety, 1997, European journal of endocrinology.

IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF‐I

M. Ranke, Z. Laron, W. Blum, 1992, Clinical endocrinology.

Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH.

Z. Laron, I. Gil-ad, R. Lewin, 1990, Acta endocrinologica.

A child with phenotypic Laron dwarfism and normal somatomedin levels.

Z. Laron, A. Silbergeld, Z. Laron,, 1989, The New England journal of medicine.

Insulin‐like growth factor‐I raises serum procollagen levels in children and adults with Laron syndrome

Z. Laron, B. Klinger, A. Silbergeld, 1996, Clinical endocrinology.

The effect of serum growth factors and xyloside on molecular aging of proteoglycan in embryonal chick cartilage

Z. Zadik, Z. Nevo, A. Silbergeld, 1984, Mechanisms of Ageing and Development.

Testosterone stimulates growth of tibial epiphyseal growth plate and insulin-like growth factor-1 receptor abundance in hypophysectomized and castrated rats

M. Phillip, Y. Segev, G. Maor, 2001, Endocrine.

Hand, Foot, and Organ Size and Growth in Untreated and IGF-I Treated Patients with Laron Syndrome

Z. Laron, A. Silbergeld, Z. Laron,, 2011 .

The effect of normal human serum on proteoglycan synthesis

Z. Nevo, A. Silbergeld, Mamet Rivka, 1978 .

DECREASED INSULIN-LIKE GROWTH FACTOR-I RECEPTOR SITES ON CIRCULATING MONONUCLEAR CELLS FROM CHILDREN WITH ACUTE LEUKEMIA

Z. Laron, R. Zaizov, B. Stark, 2000, Pediatric hematology and oncology.

Differential effects of hGH and IGF-I on body proportions.

Z. Laron, R. Kauli, A. Silbergeld, 2012, Anthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur.

Prolactin response to growth hormone stimulation tests.

Z. Laron, A. Silbergeld, Chen Barazani, 2022, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome.

L. Meacham, J. Parks, Z. Laron, 1993, The Journal of clinical endocrinology and metabolism.

Effect of octreotide on 24-hour growth hormone and prolactin secretory patterns in acromegalics.

A. Harris, Z. Laron, I. Ashkenazi, 1991, Hormone research.

Serum and renal IGF-I levels after uninephrectomy in the rat.

G. Boner, A. Erman, J. Shohat, 1997, Scandinavian journal of clinical and laboratory investigation.

Lack of effect of methylphenidate on serum growth hormone (GH), GH-binding protein, and insulin-like growth factor I.

R. Weizman, R. Weitz, N. Laor, 1997, Clinical neuropharmacology.

Growth Hormone Releasing Peptide—Hexarelin—in Children: Biochemical and Growth Promoting Effects

Z. Laron, A. Silbergeld, J. Frenkel, 1996 .

INSULIN‐LIKE GROWTH FACTOR I (IGF‐I) IN HEALTHY CHILDREN, ADOLESCENTS AND ADULTS AS DETERMINED BY A RADIOIMMUNOASSAY SPECIFIC FOR THE SYNTHETIC 53–70 PEPTIDE REGION

Z. Laron, A. Silbergeld, A. Litwin, 1986, Clinical endocrinology.

Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)

D. Wilcken, Z. Laron, X. L. Wang, 1997, European journal of endocrinology.

Elimination characteristics of intravenously administered rIGF-I in Laron-type dwarfs.

Z. Laron, M. Garty, B. Klinger, 1990, Developmental pharmacology and therapeutics.

Foot Length Before and During Insulin-like Growth Factor-I Treatment of Children with Laron Syndrome Compared to Human Growth Hormone Treatment of Children with Isolated Growth Hormone Deficiency

Z. Laron, P. Lilos, A. Silbergeld, 2007, Journal of pediatric endocrinology & metabolism : JPEM.

Intronic Mutation in the Growth Hormone (GH) Receptor Gene from a Girl with Laron Syndrome and Extremely High Serum GH Binding Protein: Extended Phenotypic Study in a Very Large Pedigree

S. Amselem, H. Kanety, R. Eshet, 1997, Journal of pediatric endocrinology & metabolism : JPEM.

Can exaggerated response to a GH provocative test identify patients with partial GH insensitivity syndrome?

I. Lavi, R. Masalha, Y. Rakover, 2002, European journal of endocrinology.

Relationship between solar activity and levels of plasma growth hormone and prolactin

E. Stoupel, I. Gil-ad, M. Shimshoni, 1989 .

Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.

A. Suikkari, V. Koivisto, A. Pertzelan, 1992, Acta endocrinologica.

A Case of Laron Syndrome Diagnosed in Slovenia

C. Krz̆is̆nik, A. Silbergeld, Z. Laron,, 1994, The Journal of pediatric endocrinology.

Growth-Hormone-Resistant Syndromes

R. Eshet, A. Pertzelan, A. Silbergeld, 1986 .

Growth hormone increases plasma levels of insulin-like growth factor (IGF-I) in a teleost, the gilthead seabream (sparus aurata).

B. Cavari, B. Funkenstein, A. Silbergeld, 1989, The Journal of endocrinology.

Hand Size and Growth in Untreated and IGF-I Treated Patients with Laron Syndrome

L. Kornreich, O. Konen, P. Lilos, 2009, Journal of pediatric endocrinology & metabolism : JPEM.

Girls with Laron Syndrome Having Positive Growth Hormone Binding Protein (GHBP) are Less Retarded in Height Than Those Lacking GHBP

M. Desai, A. Silbergeld, Zvi Laron,, 1997, Journal of pediatric endocrinology & metabolism : JPEM.

Differential effect of insulin-like growth factor-I and growth hormone on hypothalamic regulation of growth hormone secretion in the rat

Abraham Weizman, Y. Koch, Z. Dickerman, 1996 .

Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children.

B. Klinger, A. Silbergeld, J. Frenkel, 1996, European journal of endocrinology.